{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:28:34Z","timestamp":1790652514001,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["722467"],"award-info":[{"award-number":["722467"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Biomaterial-associated infections are a major healthcare challenge as they are responsible for high disease burden in critically ill patients. In this study, we have developed drug-eluting antibacterial catheters to prevent catheter-related infections. Niclosamide (NIC), originally an antiparasitic drug, was incorporated into the polymeric matrix of thermoplastic polyurethane (TPU) via solvent casting, and catheters were fabricated using hot-melt extrusion technology. The mechanical and physicochemical properties of TPU polymers loaded with NIC were studied. NIC was released in a sustained manner from the catheters and exhibited in vitro antibacterial activity against\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    and\n                    <jats:italic>Staphylococcus epidermidis<\/jats:italic>\n                    . Moreover, the antibacterial efficacy of NIC-loaded catheters was validated in an in vivo biomaterial-associated infection model using a methicillin-susceptible and methicillin-resistant strain of\n                    <jats:italic>S. aureus.<\/jats:italic>\n                    The released NIC from the produced catheters reduced bacterial colonization of the catheter as well as of the surrounding tissue. In summary, the NIC-releasing hot-melt extruded catheters prevented implant colonization and reduced the bacterial colonization of peri-catheter tissue by methicillin sensitive as well as resistant\n                    <jats:italic>S. aureus<\/jats:italic>\n                    in a biomaterial-associated infection mouse model and has good prospects for preclinical development.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-16107-4","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T09:02:58Z","timestamp":1658221378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A Niclosamide-releasing hot-melt extruded catheter prevents Staphylococcus aureus experimental biomaterial-associated infection"],"prefix":"10.1038","volume":"12","author":[{"given":"Jesus Augusto","family":"Vazquez-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa","family":"Shaqour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Guarch-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Choi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Riool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Verleije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Beyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian J. A.","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"\u015awi\u0119szkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian A. J.","family":"Zaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Felici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"16107_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/seup.200390018","volume":"13","author":"P French","year":"2003","unstructured":"French, P., Tanase, D. & Goosen, J. Sensors for catheter applications. Sensors Update 13, 107\u2013153 (2003).","journal-title":"Sensors Update"},{"key":"16107_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1086\/344188","volume":"35","author":"NP O\u2019grady","year":"2002","unstructured":"O\u2019grady, N. P. et al. Guidelines for the prevention of intravascular catheter-related infections. Clin. Infect. Dis. 35, 1281\u20131307 (2002).","journal-title":"Clin. Infect. Dis."},{"key":"16107_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ajic.2011.10.001","volume":"39","author":"MA Dudeck","year":"2011","unstructured":"Dudeck, M. A. et al. National Healthcare Safety Network (NHSN) Report, data summary for 2010, device-associated module. Am. J. Infect. Control 39, 798 (2011).","journal-title":"Am. J. Infect. Control"},{"key":"16107_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1017\/ice.2020.405","volume":"42","author":"Y-M Lee","year":"2021","unstructured":"Lee, Y.-M. et al. Clinical impact of early reinsertion of a central venous catheter after catheter removal in patients with catheter-related bloodstream infections. Infect. Control Hosp. Epidemiol. 42, 162\u2013168 (2021).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"16107_CR5","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1097\/CCM.0000000000003479","volume":"46","author":"NP O\u2019Grady","year":"2018","unstructured":"O\u2019Grady, N. P. & Kadri, S. S. Central venous catheter failures: Nowhere near zero. Crit. Care Med. 46, 2054 (2018).","journal-title":"Crit. Care Med."},{"key":"16107_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ncpneph0447","volume":"3","author":"R Katneni","year":"2007","unstructured":"Katneni, R. & Hedayati, S. S. Central venous catheter-related bacteremia in chronic hemodialysis patients: Epidemiology and evidence-based management. Nat. Clin. Pract. Nephrol. 3, 256\u2013266 (2007).","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"16107_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","volume":"9","author":"T-FC Mah","year":"2001","unstructured":"Mah, T.-F.C. & O\u2019Toole, G. A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9, 34\u201339 (2001).","journal-title":"Trends Microbiol."},{"key":"16107_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","volume":"16","author":"CR Arciola","year":"2018","unstructured":"Arciola, C. R., Campoccia, D. & Montanaro, L. Implant infections: Adhesion, biofilm formation and immune evasion. Nat. Rev. Microbiol. 16, 397 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"16107_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1086\/501776","volume":"21","author":"S Saint","year":"2000","unstructured":"Saint, S., Veenstra, D. L. & Lipsky, B. A. The clinical and economic consequences of nosocomial central venous catheter-related infection: Are antimicrobial catheters useful?. Infect. Control Hosp. Epidemiol. 21, 375\u2013380 (2000).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"16107_CR10","doi-asserted-by":"publisher","DOI":"10.1021\/acsmacrolett.7b00879","volume-title":"Antimicrobial and Antifouling Strategies for Polymeric Medical Devices","author":"ZK Zander","year":"2018","unstructured":"Zander, Z. K. & Becker, M. L. Antimicrobial and Antifouling Strategies for Polymeric Medical Devices (ACS Publications, 2018)."},{"key":"16107_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","volume":"4","author":"MA Farha","year":"2019","unstructured":"Farha, M. A. & Brown, E. D. Drug repurposing for antimicrobial discovery. Nat. Microbiol. 4, 565\u2013577 (2019).","journal-title":"Nat. Microbiol."},{"key":"16107_CR12","volume-title":"World Health Organization Model List of Essential Medicines: 21st List 2019","author":"Organization WH","year":"2019","unstructured":"Organization WH. World Health Organization Model List of Essential Medicines: 21st List 2019 (World Health Organization, 2019)."},{"key":"16107_CR13","doi-asserted-by":"publisher","first-page":"e0124595","DOI":"10.1371\/journal.pone.0124595","volume":"10","author":"R Rajamuthiah","year":"2015","unstructured":"Rajamuthiah, R. et al. Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus. PLoS ONE 10, e0124595 (2015).","journal-title":"PLoS ONE"},{"key":"16107_CR14","doi-asserted-by":"publisher","first-page":"045010","DOI":"10.1088\/1748-605X\/aa7105","volume":"12","author":"T Gwisai","year":"2017","unstructured":"Gwisai, T. et al. Repurposing niclosamide as a versatile antimicrobial surface coating against device-associated, hospital-acquired bacterial infections. Biomed. Mater. 12, 045010 (2017).","journal-title":"Biomed. Mater."},{"key":"16107_CR15","doi-asserted-by":"publisher","first-page":"e0246803","DOI":"10.1371\/journal.pone.0246803","volume":"16","author":"AD Brunaugh","year":"2021","unstructured":"Brunaugh, A. D. et al. Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae. PLoS ONE 16, e0246803 (2021).","journal-title":"PLoS ONE"},{"key":"16107_CR16","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.bmcl.2019.03.032","volume":"29","author":"J Xu","year":"2019","unstructured":"Xu, J. et al. Discovery of niclosamide and its O-alkylamino-tethered derivatives as potent antibacterial agents against carbapenemase-producing and\/or colistin resistant Enterobacteriaceae isolates. Bioorg. Med. Chem. Lett. 29, 1399\u20131402 (2019).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"16107_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2217\/fmb-2016-0021","volume":"11","author":"S Das","year":"2016","unstructured":"Das, S., Dasgupta, A. & Chopra, S. Drug repurposing: A new front in the war against Staphylococcus aureus. Future Microbiol. 11, 1091\u20131099 (2016).","journal-title":"Future Microbiol."},{"key":"16107_CR18","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1128\/AAC.00377-16","volume":"60","author":"NS Torres","year":"2016","unstructured":"Torres, N. S. et al. Screening a commercial library of pharmacologically active small molecules against Staphylococcus aureus biofilms. Antimicrob. Agents Chemother. 60, 5663\u20135672 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"16107_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1134\/S0026261717040154","volume":"86","author":"M Zhurina","year":"2017","unstructured":"Zhurina, M. et al. Niclosamide as a promising antibiofilm agent. Microbiology 86, 455\u2013462 (2017).","journal-title":"Microbiology"},{"key":"16107_CR20","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.3390\/ijms21093034","volume":"21","author":"S Gilbert-Girard","year":"2020","unstructured":"Gilbert-Girard, S., Savijoki, K., Yli-Kauhaluoma, J. & Fallarero, A. Optimization of a high-throughput 384-well plate-based screening platform with Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 15442 biofilms. Int. J. Mol. Sci. 21, 3034 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"16107_CR21","unstructured":"Whitesell, J. K. The Merck Index, CD-ROM (Macintosh): an encyclopedia of chemicals, drugs & biologicals. (eds Budavari, S. et al.) (Merck & Co., Inc., Chapman & Hall, 1997) $250.00. ISBN 0-412-75940-3 (1998)."},{"key":"16107_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cellsig.2017.04.001","volume":"41","author":"W Chen","year":"2018","unstructured":"Chen, W., Mook, R. A. Jr., Premont, R. T. & Wang, J. Niclosamide: Beyond an antihelminthic drug. Cell. Signal. 41, 89\u201396 (2018).","journal-title":"Cell. Signal."},{"key":"16107_CR23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/cmdc.201800100","volume":"13","author":"H Kadri","year":"2018","unstructured":"Kadri, H., Lambourne, O. A. & Mehellou, Y. Niclosamide, a drug with many (re)purposes. ChemMedChem 13, 1088\u20131091 (2018).","journal-title":"ChemMedChem"},{"key":"16107_CR24","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1038\/s41598-018-22037-x","volume":"8","author":"N Tharmalingam","year":"2018","unstructured":"Tharmalingam, N., Port, J., Castillo, D. & Mylonakis, E. Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori. Sci. Rep. 8, 3701 (2018).","journal-title":"Sci. Rep."},{"key":"16107_CR25","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.ijantimicag.2018.02.003","volume":"51","author":"H Mohammad","year":"2018","unstructured":"Mohammad, H., AbdelKhalek, A., Abutaleb, N. S. & Seleem, M. N. Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci. Int. J. Antimicrob. Agents 51, 897\u2013904 (2018).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"16107_CR26","doi-asserted-by":"publisher","first-page":"e02574-18","DOI":"10.1128\/AAC.02574-18","volume":"63","author":"R Domalaon","year":"2019","unstructured":"Domalaon, R., De Silva, P. M., Kumar, A., Zhanel, G. G. & Schweizer, F. The anthelmintic drug niclosamide synergizes with colistin and reverses colistin resistance in Gram-negative bacilli. Antimicrob. Agents Chemother. 63, e02574-18 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"16107_CR27","doi-asserted-by":"publisher","first-page":"e02068-20","DOI":"10.1128\/mBio.02068-20","volume":"11","author":"JN Copp","year":"2020","unstructured":"Copp, J. N. et al. Mechanistic understanding enables the rational design of salicylanilide combination therapies for Gram-negative infections. MBio 11, e02068-20 (2020).","journal-title":"MBio"},{"key":"16107_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijpharm.2017.06.076","volume":"529","author":"G Verstraete","year":"2017","unstructured":"Verstraete, G. et al. Thermoplastic polyurethane-based intravaginal rings for prophylaxis and treatment of (recurrent) bacterial vaginosis. Int. J. Pharm. 529, 218\u2013226 (2017).","journal-title":"Int. J. Pharm."},{"key":"16107_CR29","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/pharmaceutics13060772","volume":"13","author":"B Shaqour","year":"2021","unstructured":"Shaqour, B. et al. Coupling additive manufacturing with hot melt extrusion technologies to validate a ventilator-associated pneumonia mouse model. Pharmaceutics 13, 772 (2021).","journal-title":"Pharmaceutics"},{"key":"16107_CR30","first-page":"102467","volume":"49","author":"B Shaqour","year":"2021","unstructured":"Shaqour, B. et al. Novel design for an additively manufactured nozzle to produce tubular scaffolds via fused filament fabrication. Addit. Manuf. 49, 102467 (2021).","journal-title":"Addit. Manuf."},{"key":"16107_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"16107_CR32","unstructured":"ISO IJISG, Switzerland. 527\u20131: 2019 Plastics-Determination of Tensile Properties-Part 1: General Principles. 1\u201326 (2019)."},{"key":"16107_CR33","doi-asserted-by":"publisher","first-page":"100262","DOI":"10.1016\/j.jics.2021.100262","volume":"98","author":"SS Kapale","year":"2021","unstructured":"Kapale, S. S. & Chaudhari, H. K. Niclosamide & challenges in chemical modifications: A broad review on enhancement of solubility. J. Indian Chem. Soc. 98, 100262 (2021).","journal-title":"J. Indian Chem. Soc."},{"key":"16107_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijpharm.2017.06.007","volume":"528","author":"V Pardhi","year":"2017","unstructured":"Pardhi, V. et al. Preparation, characterization, and cytotoxicity studies of niclosamide loaded mesoporous drug delivery systems. Int. J. Pharm. 528, 202\u2013214 (2017).","journal-title":"Int. J. Pharm."},{"key":"16107_CR35","doi-asserted-by":"crossref","unstructured":"Sabee MM, Awang M, Bustami Y, Hamid ZA. Gentamicin loaded PLA microspheres susceptibility against Staphylococcus aureus and Escherichia coli by Kirby-Bauer and micro-dilution methods. In AIP Conference Proceedings). AIP Publishing LLC (2020).","DOI":"10.1063\/5.0017438"},{"key":"16107_CR36","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. M07","author":"MP Weinstein","year":"2018","unstructured":"Weinstein, M. P. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. M07 11th edn. (Clinical and Laboratoy Standards Institute, 2018).","edition":"11"},{"key":"16107_CR37","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.1038\/s41598-021-86155-9","volume":"11","author":"S Mandel","year":"2021","unstructured":"Mandel, S. et al. OMN6 a novel bioengineered peptide for the treatment of multidrug resistant Gram negative bacteria. Sci. Rep. 11, 6603 (2021).","journal-title":"Sci. Rep."},{"key":"16107_CR38","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1021\/jz402762h","volume":"5","author":"K-Y Law","year":"2014","unstructured":"Law, K.-Y. Definitions for hydrophilicity, hydrophobicity, and superhydrophobicity: Getting the basics right. J. Phys. Chem. Lett. 5, 686\u2013688 (2014).","journal-title":"J. Phys. Chem. Lett."},{"key":"16107_CR39","doi-asserted-by":"publisher","first-page":"170611","DOI":"10.1098\/rsos.170611","volume":"4","author":"S Naqvi","year":"2017","unstructured":"Naqvi, S., Mohiyuddin, S. & Gopinath, P. Niclosamide loaded biodegradable chitosan nanocargoes: An in vitro study for potential application in cancer therapy. R. Soc. Open Sci. 4, 170611 (2017).","journal-title":"R. Soc. Open Sci."},{"key":"16107_CR40","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.1021\/acsbiomaterials.9b01185","volume":"5","author":"E Mathew","year":"2019","unstructured":"Mathew, E. et al. Fused deposition modeling as an effective tool for anti-infective dialysis catheter fabrication. ACS Biomater. Sci. Eng. 5, 6300\u20136310 (2019).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"16107_CR41","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.saa.2014.04.050","volume":"132","author":"HE Zaazaa","year":"2014","unstructured":"Zaazaa, H. E., Abdelrahman, M. M., Ali, N. W., Magdy, M. A. & Abdelkawy, M. Kinetic study and mechanism of Niclosamide degradation. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 132, 655\u2013662 (2014).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"16107_CR42","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.msec.2018.10.027","volume":"94","author":"L Jiang","year":"2019","unstructured":"Jiang, L. et al. Electrospun nanofibrous thermoplastic polyurethane\/poly (glycerol sebacate) hybrid scaffolds for vocal fold tissue engineering applications. Mater. Sci. Eng., C 94, 740\u2013749 (2019).","journal-title":"Mater. Sci. Eng., C"},{"key":"16107_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1515\/epoly-2019-0004","volume":"19","author":"S Zhang","year":"2019","unstructured":"Zhang, S. & Ma, J. Study on the unsaturated hydrogen bond behavior of bio-based polyamide 56. E-Polymers 19, 23\u201331 (2019).","journal-title":"E-Polymers"},{"key":"16107_CR44","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1021\/cg300784v","volume":"12","author":"P Sanphui","year":"2012","unstructured":"Sanphui, P., Kumar, S. S. & Nangia, A. Pharmaceutical cocrystals of niclosamide. Cryst. Growth Des. 12, 4588\u20134599 (2012).","journal-title":"Cryst. Growth Des."},{"key":"16107_CR45","unstructured":"Witzleben, S. T., Walbrueck, K., Klein, S. E. & Schulze, M. Investigation of temperature dependency of morphological properties of thermoplastic polyurethane using WAXS and SAXS monitoring. (2015)."},{"key":"16107_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/pharmaceutics13010097","volume":"13","author":"MO Jara","year":"2021","unstructured":"Jara, M. O., Warnken, Z. N. & Williams, R. O. Amorphous solid dispersions and the contribution of nanoparticles to in vitro dissolution and in vivo testing: Niclosamide as a case study. Pharmaceutics 13, 97 (2021).","journal-title":"Pharmaceutics"},{"key":"16107_CR47","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/polym12081628","volume":"12","author":"S Cho","year":"2020","unstructured":"Cho, S., Lee, E., Jo, S., Kim, G. M. & Kim, W. Extrusion characteristics of thin walled tubes for catheters using thermoplastic elastomer. Polymers 12, 1628 (2020).","journal-title":"Polymers"},{"key":"16107_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/pharmaceutics12060517","volume":"12","author":"B Shaqour","year":"2020","unstructured":"Shaqour, B. et al. Production of drug delivery systems using fused filament fabrication: A systematic review. Pharmaceutics 12, 517 (2020).","journal-title":"Pharmaceutics"},{"key":"16107_CR49","volume-title":"Antimicrobial Resistance: Global Report on Surveillance","author":"Organization WH","year":"2014","unstructured":"Organization WH. Antimicrobial Resistance: Global Report on Surveillance (World Health Organization, 2014)."},{"key":"16107_CR50","doi-asserted-by":"crossref","unstructured":"Chang, Y-W., Yeh, T-K., Lin, K-T., Chen, W-C. & Yao, H-T. Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats. J. Food Drug Anal. 14, (2006).","DOI":"10.38212\/2224-6614.2464"},{"key":"16107_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejpb.2019.05.004","volume":"141","author":"EJ Barbosa","year":"2019","unstructured":"Barbosa, E. J., L\u00f6benberg, R., de Araujo, G. L. B. & Bou-Chacra, N. A. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities. Eur. J. Pharm. Biopharm. 141, 58\u201369 (2019).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"16107_CR52","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.lanepe.2021.100084","volume":"4","author":"V Backer","year":"2021","unstructured":"Backer, V. et al. A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19. Lancet Reg. Health-Eur. 4, 100084 (2021).","journal-title":"Lancet Reg. Health-Eur."},{"key":"16107_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-85969-x","volume":"11","author":"M Parikh","year":"2021","unstructured":"Parikh, M. et al. Phase Ib trial of reformulated niclosamide with abiraterone\/prednisone in men with castration-resistant prostate cancer. Sci. Rep. 11, 1\u20137 (2021).","journal-title":"Sci. Rep."},{"key":"16107_CR54","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fphar.2017.00110","volume":"8","author":"S Hamdoun","year":"2017","unstructured":"Hamdoun, S., Jung, P. & Efferth, T. Drug repurposing of the anthelmintic niclosamide to treat multidrug-resistant leukemia. Front. Pharmacol. 8, 110\u2013110 (2017).","journal-title":"Front. Pharmacol."},{"key":"16107_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpddr.2018.12.004","volume":"9","author":"JL Zhang","year":"2019","unstructured":"Zhang, J. L. et al. New life for an old drug: in vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain. Int. J. Parasitol. Drugs Drug Resist. 9, 27\u201334 (2019).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"16107_CR56","doi-asserted-by":"crossref","unstructured":"Brunaugh, A. D. et al. Broad-spectrum, patient-adaptable inhaled niclosamide-lysozyme particles are efficacious against coronaviruses in lethal murine infection models. BioRxiv (2020).","DOI":"10.1101\/2020.09.24.310490"},{"key":"16107_CR57","doi-asserted-by":"publisher","first-page":"120701","DOI":"10.1016\/j.ijpharm.2021.120701","volume":"603","author":"MO Jara","year":"2021","unstructured":"Jara, M. O. et al. Niclosamide inhalation powder made by thin-film freezing: Multi-dose tolerability and exposure in rats and pharmacokinetics in hamsters. Int. J. Pharm. 603, 120701 (2021).","journal-title":"Int. J. Pharm."},{"key":"16107_CR58","doi-asserted-by":"publisher","first-page":"8993","DOI":"10.18632\/oncotarget.7113","volume":"7","author":"C-K Lin","year":"2016","unstructured":"Lin, C.-K. et al. Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer. Oncotarget 7, 8993 (2016).","journal-title":"Oncotarget"},{"key":"16107_CR59","doi-asserted-by":"publisher","first-page":"49387","DOI":"10.1002\/app.49387","volume":"137","author":"M Nofar","year":"2020","unstructured":"Nofar, M., Mohammadi, M. & Carreau, P. J. Effect of TPU hard segment content on the rheological and mechanical properties of PLA\/TPU blends. J. Appl. Polym. Sci. 137, 49387 (2020).","journal-title":"J. Appl. Polym. Sci."},{"key":"16107_CR60","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.3390\/ma12182972","volume":"12","author":"D Kowalczuk","year":"2019","unstructured":"Kowalczuk, D. & Pitucha, M. Application of FTIR method for the assessment of immobilization of active substances in the matrix of biomedical materials. Materials 12, 2972 (2019).","journal-title":"Materials"},{"key":"16107_CR61","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/coatings10090818","volume":"10","author":"D Kowalczuk","year":"2020","unstructured":"Kowalczuk, D. FTIR characterization of the development of antimicrobial catheter coatings loaded with fluoroquinolones. Coatings 10, 818 (2020).","journal-title":"Coatings"},{"key":"16107_CR62","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.xphs.2015.10.008","volume":"105","author":"S Baghel","year":"2016","unstructured":"Baghel, S., Cathcart, H. & O\u2019Reilly, N. J. Polymeric amorphous solid dispersions: A review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J. Pharm. Sci. 105, 2527\u20132544 (2016).","journal-title":"J. Pharm. Sci."},{"key":"16107_CR63","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3390\/polym10121379","volume":"10","author":"SA Stewart","year":"2018","unstructured":"Stewart, S. A., Dom\u00ednguez-Robles, J., Donnelly, R. F. & Larra\u00f1eta, E. Implantable polymeric drug delivery devices: Classification, manufacture, materials, and clinical applications. Polymers 10, 1379 (2018).","journal-title":"Polymers"},{"key":"16107_CR64","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S1367-5931(00)00227-1","volume":"5","author":"O Pillai","year":"2001","unstructured":"Pillai, O. & Panchagnula, R. Polymers in drug delivery. Curr. Opin. Chem. Biol. 5, 447\u2013451 (2001).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"16107_CR65","doi-asserted-by":"publisher","first-page":"2002962","DOI":"10.1002\/adma.202002962","volume":"32","author":"S Amin Yavari","year":"2020","unstructured":"Amin Yavari, S., Castenmiller, S. M., van Strijp, J. A. & Croes, M. Combating implant infections: Shifting focus from bacteria to host. Adv. Mater. 32, 2002962 (2020).","journal-title":"Adv. Mater."},{"key":"16107_CR66","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/antibiotics4040424","volume":"4","author":"QY Lau","year":"2015","unstructured":"Lau, Q. Y. et al. An FDA-drug library screen for compounds with bioactivities against meticillin-resistant Staphylococcus aureus (MRSA). Antibiotics 4, 424\u2013434 (2015).","journal-title":"Antibiotics"},{"key":"16107_CR67","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/antibiotics3030378","volume":"3","author":"J Nowakowska","year":"2014","unstructured":"Nowakowska, J., Landmann, R. & Khanna, N. Foreign body infection models to study host-pathogen response and antimicrobial tolerance of bacterial biofilm. Antibiotics 3, 378\u2013397 (2014).","journal-title":"Antibiotics"},{"key":"16107_CR68","doi-asserted-by":"publisher","first-page":"e02068-02020","DOI":"10.1128\/mBio.02068-20","volume":"11","author":"JN Copp","year":"2020","unstructured":"Copp, J. N. et al. Mechanistic understanding enables the rational design of salicylanilide combination therapies for Gram-negative infections. MBio 11, e02068-02020 (2020).","journal-title":"MBio"},{"key":"16107_CR69","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2217\/fmb.10.89","volume":"5","author":"SAJ Zaat","year":"2010","unstructured":"Zaat, S. A. J., Broekhuizen, C. A. N. & Riool, M. Host tissue as a niche for biomaterial-associated infection. Future Microbiol. 5, 1149\u20131151 (2010).","journal-title":"Future Microbiol."},{"key":"16107_CR70","doi-asserted-by":"crossref","unstructured":"Zaat, S. A. J. Tissue colonization in biomaterial-associated infection. In Biomaterials Associated Infection (Springer, 2013).","DOI":"10.1007\/978-1-4614-1031-7_8"},{"key":"16107_CR71","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/cid\/ciq108","volume":"52","author":"LA Mermel","year":"2011","unstructured":"Mermel, L. A. What is the predominant source of intravascular catheter infections?. Clin. Infect. Dis. 52, 211\u2013212 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"16107_CR72","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/medicines7090049","volume":"7","author":"C Casimero","year":"2020","unstructured":"Casimero, C. et al. Minimising blood stream infection: Developing new materials for intravascular catheters. Medicines 7, 49 (2020).","journal-title":"Medicines"},{"key":"16107_CR73","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1124\/dmd.119.086744","volume":"47","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Drug concentration asymmetry in tissues and plasma for small molecule\u2013related therapeutic modalities. Drug Metab. Dispos. 47, 1122\u20131135 (2019).","journal-title":"Drug Metab. Dispos."},{"key":"16107_CR74","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1002\/jcp.29413","volume":"235","author":"S Thatikonda","year":"2020","unstructured":"Thatikonda, S., Pooladanda, V. & Godugu, C. Repurposing an old drug for new use: Niclosamide in psoriasis-like skin inflammation. J. Cell. Physiol. 235, 5270\u20135283 (2020).","journal-title":"J. Cell. Physiol."},{"key":"16107_CR75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lfs.2018.12.061","volume":"220","author":"R Boyapally","year":"2019","unstructured":"Boyapally, R., Pulivendala, G., Bale, S. & Godugu, C. Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt\/\u03b2-catenin signaling: A drug repurposing study. Life Sci. 220, 8\u201320 (2019).","journal-title":"Life Sci."},{"key":"16107_CR76","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00011-015-0801-5","volume":"64","author":"L Liang","year":"2015","unstructured":"Liang, L. et al. Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Inflamm. Res. 64, 225\u2013233 (2015).","journal-title":"Inflamm. Res."},{"key":"16107_CR77","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1158\/1535-7163.MCT-13-0555","volume":"13","author":"AI Londo\u00f1o-Joshi","year":"2014","unstructured":"Londo\u00f1o-Joshi, A. I. et al. Effect of niclosamide on basal-like breast cancers. Mol. Cancer. Ther. 13, 800\u2013811 (2014).","journal-title":"Mol. Cancer. Ther."},{"key":"16107_CR78","doi-asserted-by":"publisher","first-page":"113610","DOI":"10.1016\/j.bcp.2019.08.012","volume":"169","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y. et al. Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway. Biochem. Pharmacol. 169, 113610 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"16107_CR79","unstructured":"Hayes, W. J. & Laws, E. R. Handbook of Pesticide Toxicology (1991)."},{"key":"16107_CR80","unstructured":"World Health Organization. WHO Specifications and Evaluations for Public Health Pesticides: Niclosamide (2002)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16107-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16107-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16107-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T23:44:35Z","timestamp":1669333475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16107-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16107"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16107-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.10.475592","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12329"}}